Cheng Wang

7PUBLICATIONS
3CO-AUTHORS
Major global burdens of diseaseMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Medical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Oct 22, 2025
Sex difference in the burden of rheumatic heart disease: Insights from the Global Burden of Disease Study 2021.

Shushu Jiang, Jiakai Zhang, Menghao Shi

|Aug 06, 2025
Ring Finger Protein 2 Promotes Oxidative Stress and Mitochondrial Dysfunction in Doxorubicin-Induced Cardiotoxicity Via the Mercaptopyruvate Sulfurtransferase/Hydrogen Sulfide Pathway.

Yi Zhong, Di Fan, Peiyi Zhang

|Jun 10, 2025
EBBP-Mediated Integrated Stress Response Attenuates Anthracycline-Induced Cardiotoxicity by Inhibiting the Ferroptosis of Cardiomyocytes.

Zilong Chen, Can Chen, Yichen Wu

|May 11, 2021
FUNDC1-dependent mitochondria-associated endoplasmic reticulum membranes are involved in angiogenesis and neoangiogenesis.

Cheng Wang, Xiaoyan Dai, Shengnan Wu

|Oct 26, 2020
E3 Ligase FBXW2 Is a New Therapeutic Target in Obesity and Atherosclerosis.

Cheng Wang, Wenjing Xu, Yuelin Chao

|Nov 03, 2019
CTRP13 Preserves Endothelial Function by Targeting GTP Cyclohydrolase 1 in Diabetes.

Cheng Wang, Yuelin Chao, Wenjing Xu

Pageof 2

Frequent Collaborators

3 joint publications

Kai Huang

1 joint publications

Qiubai Li

1 joint publications

Shushu Jiang